Business Wire

ISACA Refreshes COBIT Framework to Address Latest Business Technology Trends and Standards

Share

ISACA, the global association for information and technology (I&T) audit, risk, governance and security professionals, has released its first update to the COBIT framework in nearly seven years. The new version, COBIT® 2019, provides comprehensive and more practical guidance to help enterprises better govern and manage their information and technology. The COBIT framework is used by enterprises in all industries around the globe, and COBIT publications have been downloaded more than one million times.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181113005757/en/

ISACA introduced COBIT in 1996 to provide and organize a set of controls for IT. The new iteration of COBIT will come in four phases and will include focus areas reflecting trends and priorities in technology (e.g., DevOps, cybersecurity), updates aligned with the latest industry standards, and a design guide that provides flexibility and guidance to help organizations tailor a governance system to their needs.

“The COBIT framework has thrived for 20-plus years because it addresses core business principles that are every bit as true now as they were in the 1990s,” said Mark Thomas, a COBIT trainer and founder of Escoute Consulting, who blogged about the COBIT update here. “But it had become important to provide updated guidance related to key drivers of the current technology landscape, and COBIT 2019 takes a big step forward in that regard.”

The first phase, released today, includes:

  • COBIT 2019 Framework: Introduction and Methodology—Details governance principles, provides key concepts and examples, and lays out the structure of the overall framework, including the COBIT Core Model.
  • COBIT 2019 Framework: Governance and Management Objectives— Provides detailed description of the COBIT Core Model and its 40 governance/management objectives, which are defined and then matched up with the related process, enterprise goals, and governance and management practices.

Both are available to ISACA members and nonmembers free of charge at www.isaca.org/cobit, and a complimentary tool kit is included.

In December, ISACA will release:

  • COBIT 2019 Design Guide: Designing an Information and Technology Governance Solution—Offers how-to information to design a tailored governance system for organizations
  • COBIT 2019 Implementation Guide: Implementing and Optimizing an Information and Technology Governance Solution—Provides a roadmap for continuous governance improvement

Training courses and certificate programs will be released in January and April.

Among the changes from COBIT 5, COBIT 2019 uses a maturity model based on the CMMI Institute’s Capability Maturity Model Integration to assess enterprises’ capability levels for each activity in COBIT. COBIT 2019 adds three additional management objectives (processes), as well as design factors.

“COBIT 2019 provides world-class guidance that can increase the value derived from information and technology assets through better governance and management,” said ISACA Board Chair Rob Clyde, CISM. “This kind of guidance spurs new growth and innovation while fortifying organizations worldwide against threats and risks.”

COBIT 2019 helps enterprises govern information and technology—from a single project-based implementation, to use by a particular team or business unit, to full, enterprisewide implementation.

“COBIT 2019 offers enterprises flexibility to design practical governance solutions specific to organizations’ business goals and their specific context,” said Dirk Steuperaert, lead developer of COBIT 2019. “Those that adopt COBIT 2019 will benefit from optimized resource use, increased efficiency, and better management of their information and technology.”

For more information about COBIT 2019 guidance, products and training, visit www.isaca.org/cobit or register for a free webinar here.

ISACA on Twitter: www.twitter.com/ISACANews

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

ISACA
Emily Van Camp, +1.847.385.7223
evcamp@isaca.org
or
Kristen Kessinger, +1.847.660.5512
kkessinger@isaca.org

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

HCLTech Reports FY24 Revenue of $13.3 Billion, up 5.4% YoY26.4.2024 22:06:00 CEST | Press release

HCLTech, a leading global technology company, today reported financial results for the fourth quarter and the full year ended March 31, 2024. The company reported full year revenue of $13.3 billion, up 5.4% YoY. Digital Services revenue grew by 5.3% (CC) and now contributes to 37.3% of IT Services revenue. HCLSoftware’s Annual Recurring Revenue came in at $1.02 billion. During FY24, the company won 73 large deals – 36 in Services and 37 in Software - that translated into TCV (new deal wins) of $9.76 billion, up 10% YoY. For the quarter, revenue came in at $3.43 billion, up 6% YoY. HCLTech won 21 large deals – 13 in Services and eight in Software, with a TCV of $2.29 billion during the quarter. In terms of geographies, Americas was the fastest growing region with 6.8% YoY (CC) growth followed by Europe, which grew by 5.5% YoY (CC). Industry vertical growth was led by Financial Services and Telecommunications, Media, Publishing & Entertainment. While Financial Services grew at 12.1% YoY

Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadrant™ for Supply Chain Planning Solutions26.4.2024 18:03:00 CEST | Press release

Kinaxis® Inc. (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced it has been named a Leader in the 2024 Gartner® Magic Quadrant™ for Supply Chain Planning Solutions. Of the 20 vendors evaluated, Gartner positioned Kinaxis highest on Ability to Execute, marking the company’s 10th consecutive Leaders Quadrant within the report, a complimentary copy of which can be downloaded here. Kinaxis attributes its position to its patented concurrency approach and a proven track record of delivering innovative solutions against the foundation of its leading vision through the use of advanced technology such as AI, ML, and an intuitive user experience. Bolstered by a rich ecosystem of third-party implementation partners, Kinaxis continues to demonstrate that regardless of a customer’s industry, size, or maturity level, the company can be counted on to seamlessly orchestrate supply chain networks end-to-end from strategic planning to last-mile delivery. The recognitio

Vertex Announces European Commission Approval for KALYDECO ® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older26.4.2024 17:43:00 CEST | Press release

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for the label expansion of KALYDECO® (ivacaftor) for the treatment of infants down to 1 month of age with cystic fibrosis (CF) who have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: R117H, G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. “Today’s approval is an important milestone for the cystic fibrosis community. Treating CF early in life can potentially slow the progression of the disease, which is why it is so important to start treatment from a very young age,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer, Vertex. As a result of existing access agreements in Austria, Czech Republic, Denmark, Ireland, Norway, Sweden, and The Netherlands, eligible patients will have access to the expanded indication of KALYDECO® (ivacaftor)

Suzano 2023 annual report on Form 20-F26.4.2024 17:22:00 CEST | Press release

Suzano S.A. (B3: SUZB3 | NYSE: SUZ) informs that its 2023 Annual Report on Form 20-F was filed today with the U.S. Securities and Exchange Commission. Holders of the Company’s equity securities can receive hard copies of the Annual Report, including its audited financial statements, without charge by request directed to: ri@suzano.com.br. This document is also available on Suzano’s website (http://ir.suzano.com.br/). For further information, please contact our Investor Relations Department: Phone: (+55 11) 3503-9330 E-mail: ri@suzano.com.br View source version on businesswire.com: https://www.businesswire.com/news/home/20240426289818/en/Contact information Hawthorn Advisors suzano@hawthornadvisors.com

Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer26.4.2024 14:30:00 CEST | Press release

Takeda (TSE:4502/NYSE:TAK) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of fruquintinib, a selective inhibitor of vascular endothelial growth factor receptors (VEGFR) -1, -2 and -3 for the treatment of adult patients with previously treated metastatic colorectal cancer (mCRC). The European Commission (EC) will consider the CHMP positive opinion when determining the potential marketing authorization for fruquintinib for mCRC throughout the European Union (EU), Norway, Liechtenstein and Iceland. If approved, fruquintinib will be the first and only selective inhibitor of all three VEGF receptors approved in the EU for previously treated mCRC.1,2 “People living with metastatic colorectal cancer in the European Union currently have limited treatment options, which can lead to poor outcomes. With this positive opinion for fruquintinib, we are one step closer to potentially offering patients a new

HiddenA line styled icon from Orion Icon Library.Eye